[국내논문]사료급이(oral feeding)에 의한 vaccination을 통한 흰반점바이러스(WSSV)에 대한 재조합단백질 rVP19+28의 백신효능의 확인 Vaccination of Shrimp (Litopenaeus vannamei) against White Spot Syndrome Virus (WSSV) by Oral Vaccination of Recombinant Fusion Protein, rVP19+28원문보기
본 연구는 WSSV의 주요 구조단백질인 VP19와 VP28을 모두 포함하는 VP19+28 fusion protein을 제조하여, Litopenaeus vannamei에서 WSSV에 대한 백신으로서의 효능을 평가하고자 수행하였다. VP19와 VP28 유전자를 fusion하여 제작한 VP19+28 유전자를 pET-28a(+) vector에 삽입하고 단일단백질로서 제작된 VP19+28 유전자를 E. coli BL21 (DE3)에서 발현시켰다. 백신실험을 위해 새우에게 2주 동안 실험용 사료를 급이하였으며, 그 후 바이러스액($1{\times}10^2$배로 희석한 WSSV)을 이용하여 새우에게 주사 감염에 의해 in vivo 공격실험(challenge test)을 수행하였다. 실험결과, vaccination을 하지 않은 새우들은 감염 후 11일째에 100%의 누적폐사율을 보였으며, host control로써 E. coli BL21을 사용하여 vaccination한 새우들은 감염 후 17일째에 100%의 누적폐사율을 보였다. rVP19, rVP28, rVP19+28을 이용하여 vaccination한 새우들의 경우 감염 후 21일째에 각각 66.7%, 41.7%, 41.7%의 누적폐사율을 보였다. 이상의 결과를 통해 rVP28과 rVP19+28이 WSSV에 대해 높은 백신효능을 가짐을 확인하였다. 또한 감염 후 21일째에 fusion protein rVP19+28과 rVP28의 누적폐사율은 동일하였지만 공격실험기간 동안 폐사율이 rVP19+28을 투여 한 실험군이 낮게 나타나는 것을 보아 WSSV에 대한 새우의 방어효능은 rVP19+28이 더 높음을 나타내는 것이다.
본 연구는 WSSV의 주요 구조단백질인 VP19와 VP28을 모두 포함하는 VP19+28 fusion protein을 제조하여, Litopenaeus vannamei에서 WSSV에 대한 백신으로서의 효능을 평가하고자 수행하였다. VP19와 VP28 유전자를 fusion하여 제작한 VP19+28 유전자를 pET-28a(+) vector에 삽입하고 단일단백질로서 제작된 VP19+28 유전자를 E. coli BL21 (DE3)에서 발현시켰다. 백신실험을 위해 새우에게 2주 동안 실험용 사료를 급이하였으며, 그 후 바이러스액($1{\times}10^2$배로 희석한 WSSV)을 이용하여 새우에게 주사 감염에 의해 in vivo 공격실험(challenge test)을 수행하였다. 실험결과, vaccination을 하지 않은 새우들은 감염 후 11일째에 100%의 누적폐사율을 보였으며, host control로써 E. coli BL21을 사용하여 vaccination한 새우들은 감염 후 17일째에 100%의 누적폐사율을 보였다. rVP19, rVP28, rVP19+28을 이용하여 vaccination한 새우들의 경우 감염 후 21일째에 각각 66.7%, 41.7%, 41.7%의 누적폐사율을 보였다. 이상의 결과를 통해 rVP28과 rVP19+28이 WSSV에 대해 높은 백신효능을 가짐을 확인하였다. 또한 감염 후 21일째에 fusion protein rVP19+28과 rVP28의 누적폐사율은 동일하였지만 공격실험기간 동안 폐사율이 rVP19+28을 투여 한 실험군이 낮게 나타나는 것을 보아 WSSV에 대한 새우의 방어효능은 rVP19+28이 더 높음을 나타내는 것이다.
This study was carried out to evaluate the vaccination effects of recombinant fusion protein rVP19+28 against WSSV in shrimp, Litopenaeus vannamei. The VP19+28 gene fused with VP19 and VP28 genes was inserted into pET-28a(+) expression vector and cloned in E. coli BL21 (DE3) to produce fused gene pr...
This study was carried out to evaluate the vaccination effects of recombinant fusion protein rVP19+28 against WSSV in shrimp, Litopenaeus vannamei. The VP19+28 gene fused with VP19 and VP28 genes was inserted into pET-28a(+) expression vector and cloned in E. coli BL21 (DE3) to produce fused gene product recombinant VP19+VP28 as a single protein. For the vaccination, the shrimps were fed with pellets coated with purified recombinant protein, rVP19+28, for 2 weeks. Then, constant amounts of WSSV at $1{\times}10^2$ diluted stocks were injected to the muscle of the shrimp for the in vivo challenge tests. Non-vaccinated shrimps showed a cumulative mortality of 100% at 11 days post-challenge. The shrimps vaccinated with the inactivated E. coli BL21 as a host cell control showed cumulative mortality of 100% at 17 days post-challenge. The shrimps vaccinated with rVP19, rVP28 and rVP19+28 showed mortalities of 66.7%, 41.7% and 41.7% at 21 days post-challenge, respectively. These results indicated that the rVP28 and rVP19+28 had relatively high vaccination effects against WSSV infection. However, this study suggests that the fusion protein rVP19+28 was more effective for the protection of shrimp against WSSV than rVP28, even though the cumulative mortalities were the same 21 days post-challenge.
This study was carried out to evaluate the vaccination effects of recombinant fusion protein rVP19+28 against WSSV in shrimp, Litopenaeus vannamei. The VP19+28 gene fused with VP19 and VP28 genes was inserted into pET-28a(+) expression vector and cloned in E. coli BL21 (DE3) to produce fused gene product recombinant VP19+VP28 as a single protein. For the vaccination, the shrimps were fed with pellets coated with purified recombinant protein, rVP19+28, for 2 weeks. Then, constant amounts of WSSV at $1{\times}10^2$ diluted stocks were injected to the muscle of the shrimp for the in vivo challenge tests. Non-vaccinated shrimps showed a cumulative mortality of 100% at 11 days post-challenge. The shrimps vaccinated with the inactivated E. coli BL21 as a host cell control showed cumulative mortality of 100% at 17 days post-challenge. The shrimps vaccinated with rVP19, rVP28 and rVP19+28 showed mortalities of 66.7%, 41.7% and 41.7% at 21 days post-challenge, respectively. These results indicated that the rVP28 and rVP19+28 had relatively high vaccination effects against WSSV infection. However, this study suggests that the fusion protein rVP19+28 was more effective for the protection of shrimp against WSSV than rVP28, even though the cumulative mortalities were the same 21 days post-challenge.
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
제안 방법
This study was carried out to evaluate the recombinant fusion protein rVP19+28 including both VP19 and VP28 as quasi-vaccines for the oral administration.
대상 데이터
Ten μl of different virus dilutions were injected in the second abdominal segment of the shrimp using a 30-gauge needle. For each group, fifteen shrimps were used in the challenge test. Mortality was recorded daily and dead shrimps were tested for the presence of WSSV by PCR.
Healthy shrimps (Litopenaeus vannamei) were purchased from a shrimp farm located Muan, Jeonnam, Korea. Shrimps of 6 to 8 g were used in experiments.
After the injection, the shrimp mortality was monitored daily. The experiments were conducted in triplicate.
The virus particle of WSSV consists of 6 major proteins such as VP15, VP19, VP24, VP26, VP28 and VP664. In addition to major proteins, 40 WSSV proteins have been characterized [1].
성능/효과
For the determination of dilution ratio resulting 100% mortality of shrimp in desired period of experiments, in vivo virus titration was performed. As shown in Fig. 3, the results of in vivo titration showed 50-100% mortalities in all tested groups at 14 days of post challenge. Administration of virus dilutions of 1×101 and 1×102 resulted in 100% mortality in less than 9 days of post challenge.
In this study, the vaccinated shrimps by oral feeding showed low cumulative mortalities compared to control groups. The rVP28 and rVP19+28 had better protective effect than rVP19.
coli BL21 as a host cell control showed cumulative mortality of 100% at 17 days of post challenge. The shrimps vaccinated with rVP19, rVP28 and rVP19+28 showed 66.7%, 41.7% and 41.7% of mortalities at 21 days of post challenge, respectively. These results indicated that the rVP28 and rVP19+28 had the relative high vaccination effects against WSSV infection.
후속연구
This opens the way to design new strategies for the treatment of WSSV and other invertebrate pathogens. Further studies on the long term protection from WSSV after the vaccination of shrimp with rVP19+28 as a protein oral vaccine should be carried out.
참고문헌 (10)
Escobedo-Bonilla, C. M., V. Alday-Sanz, M. Wille, P. Sorgeloos, M. B. Pensaert, and H. J. Nauwynck. 2008. A review on the morphology, molecular characterization, morphogenesis and pathogenesis of white spot syndrome virus. J. Fish Dis. 31, 1-18.
Rojtinnakorn, J., I. Hirono, T. Itami, Y. Takahashi, and T. Aoki. 2002. Gene expression in haemocytes of kuruma prawn, Penaeus japonicus, in response to infection with WSSV by EST approach. Fish Shellfish Immunol. 13, 69-83.
Roux, M. M., A. Pain, K. R. Klimpel, and A. K. Dhar. 2002. The lipopolysaccharide and $\beta$ -1, 3-glucan binding protein gene is upregulated in white spot virus-infected shrimp (Penaeus stylirostris). J. Virol. 76, 7140-7149.
Van Hulten, M. C. W., J. Witteveldt, M. Snippe, and J. M. Vlak. 2001. White spot syndrome virus envelop protein VP28 is involved in the systemic infection of shrimp. Virology 285, 228-233.
Venegas, C. A., L. Nonaka, K. Mushiake, T. Nishizawa, and K. Muroga. 2000. Quasi-immune response of Penaeus japonicus to penaeid rod-shaped DNA virus (PRDV). Dis. Aquat. Org. 42, 83-89.
Vlak, J. M., J. R. Bonami, T. W. Flegel, G. H. Kou, D. V. Lightner, C. F. Loh, P. C. Loh, and P. W. Walker. 2005. Nimaviridae, pp. 1162, Virus Taxonomy: Eighth Report of the International Committee on Taxonomy of Viruses, Academic Press, London, UK.
Witteveldt, J., C. C. Cifuentes, J. M. Vlak, and M. C. W. Van Hulten. 2004. Protection of Penaeus monodon against white spot syndrome virus by oral vaccination. J. Virol. 78, 2057-2061.
Wu, J. L., T. Nishioka, K. Mori, T. Nishizawa, and K. A. Muroga. 2002. A time-course study on the resistance of Penaeus japonicus induced by artificial infection with white spot syndrome virus. Fish Shellfish Immunol. 13, 391-403.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.